Live Breaking News & Updates on O Scyx Us8112922005
Stay updated with breaking news from O scyx us8112922005. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GSK is set to gain exclusive rights to first-in-class oral antifungal Brexafemme for vulvovaginal candidiasis from SCYNEXIS. The exclusive licence agreement will enable GSK to commercialise. | March 30, 2023 ....